Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation

Fig. 4

a Mice treated with emodin/cisplatin had significantly smaller tumors than those in other group. b Transplanted tumors on day 18. c Average weight of transplanted tumors. d Average body weight of tumor-bearing mice on day 18. Columns, mean; bars, S.D. #p < 0.05, emodin/cisplatin co-treatment group compared with cisplatin group (n = 8)

Back to article page